Exercise in a Pill Is Now in Human Trials

• by Kerri Miller

• March 18, 2026

Oral Aleniglipron Reduced Weight at 36 Weeks

In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.

• by Kathryn Wighton

• July 16, 2026

• 6 min

Low Vitamin D Persists Year-Round in Northern Britain

Screening data from a UK clinical trial found low vitamin D levels in 55% of older patients and 72% of ethnic patients, with little variation despite summer months.

• by Andrea Surnit

• July 2, 2026

• 3 min

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min